Health Care
Billionaires Bankroll Cell Rejuvenation Tech as the Latest Gambit to Slow Aging
Start-ups bet that carefully controlled cell reprogramming may lead to age reversal, but hurdles remain
Stories by Michael Eisenstein
Genetics
Ranking the Risk of Heart Disease
By accounting for the additive effect of multiple genetic variants, researchers can develop a system that improves their ability to identify the most vulnerable
Public Health
What’s Your Risk of Catching COVID? These Tools Help You Find Out
A look at apps that predict the chance of infection and illness, depending on what you’re doing and where you are
Health
Clinical Trials: More Trials, Fewer Tribulations
Clinical studies that group patients according to their molecular profile can make for better and faster drug approval decisions
